GGrantIndex
← Leaderboards

Alban P Gaultier

University Of California, San Diego

$8,392,782
Attributed
$10,456,132
Total exposure
12
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY201125
$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,456,132 · 12

By mechanism

R21$2,733,172 · 6
RF1$2,688,657 · 1
R01$1,869,929 · 1
R33$1,320,660 · 1
R41$707,181 · 1
R43$673,853 · 1

Top collaborators

Most similar at University Of California, San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsMediatingBrainMyelinProductionIn VitroIn VivoMultiple SclerosisAlzheimer&AposProteinsNeuraxisAnimal ModelNerve DegenerationExperimental Autoimmune EncephalomyelitisImmune SystemReceptorInflammatoryPathologyImmune ResponseImmuneLightNeurodegenerative DisordersMouse ModelT-Lymphocyte

Grant awards (26)

Understanding the impact of Clusterin on the oligodendrocyte lineage in AD$1,067,122
RF1 · FY2025 · AG · contact PI
Impact of phagocytosis on amyloid beta-induced pathology$444,125
R21 · FY2023 · AG
Understanding the impact of Clusterin on the oligodendrocyte lineage in AD$1,621,535
RF1 · FY2022 · AG · contact PI
The role of oligodendrocyte progenitor cells in neuroinflammation$462,680
R56 · FY2021 · NS · contact PI
Discovering new therapies to promote myelin repair$440,030
R21 · FY2021 · NS · contact PI
NOVO-118 as a therapeutic to promote remyelination in in vivo models of MS$354,097
R41 · FY2020 · NS
Meningeal immunity - a middleman between gut microbiome and the brain$440,597
R33 · FY2019 · MH · contact PI
Diversity of oligodendrocyte precursor cells in the adult central nervous system$435,015
R21 · FY2019 · NS · contact PI
NOVO-118 as a therapeutic to promote remyelination in in vivo models of MS$353,084
R41 · FY2019 · NS
Role of LRP1 in NF-kB mediated neuroinflammation$340,310
R01 · FY2019 · NS · contact PI
Meningeal immunity - a middleman between gut microbiome and the brain$440,597
R33 · FY2018 · MH
Role of LRP1 in NF-kB mediated neuroinflammation$366,963
R01 · FY2018 · NS · contact PI
Identification of S1R as a novel checkpoint in ER mediated inflammation$238,855
R21 · FY2018 · NS · contact PI
Meningeal immunity - a middleman between gut microbiome and the brain$439,466
R33 · FY2017 · MH
Role of LRP1 in NF-kB mediated neuroinflammation$392,327
R01 · FY2017 · NS · contact PI
Identification of S1R as a novel checkpoint in ER mediated inflammation$199,668
R21 · FY2017 · NS · contact PI
Role of LRP1 in NF-kB mediated neuroinflammation$398,675
R01 · FY2016 · NS · contact PI
RAP as a novel therapeutic to promote remyelination after MS demyelinating event$320,747
R43 · FY2016 · NS
Meningeal immunity - a middleman between gut microbiome and the brain$270,426
R21 · FY2016 · MH
RAP as a novel therapeutic to promote remyelination after MS demyelinating event$353,106
R43 · FY2015 · NS
Role of LRP1 in NF-kB mediated neuroinflammation$340,310
R01 · FY2015 · NS · contact PI
Meningeal immunity - a middleman between gut microbiome and the brain$270,426
R21 · FY2015 · MH
Role of LRP1 in NF-kB mediated neuroinflammation$31,344
R01 · FY2015 · NS · contact PI
Function of LRP-1 in Multiple Sclerosis.$238,931
R21 · FY2012 · NS · contact PI
Function of LRP-1 in Multiple Sclerosis.$113,419
R21 · FY2011 · NS · contact PI
Function of LRP-1 in Multiple Sclerosis.$82,277
R21 · FY2011 · NS · contact PI